(Q35053581)

6 August 2017

title

IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia (English)

1 reference

6 August 2017

2

Stephan von Haehling

1 reference

6 August 2017

5

Stefan D Anker

1 reference

6 August 2017

4

Sandra Palus

1 reference

6 August 2017

3

Wolfram Doehner

1 reference

6 August 2017

Katja Schmidt

1

1 reference

6 August 2017

Jochen Springer

series ordinal

6

1 reference

6 August 2017

publication date

8 May 2011

1 reference

Journal of Cachexia, Sarcopenia and Muscle

6 August 2017

published in

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

105-109

1 reference

Cachexia as a major underestimated and unmet medical need: facts and numbers

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

Brown fat biology and thermogenesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

The lethal phenotype of cancer: the molecular basis of death due to malignancy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

Patient selection for IGF-I therapy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

Insulin-like growth factor-I in muscle metabolism and myotherapies.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

Studies on the mechanism of resistance to alkylating agents of three ascites tumours in the rat.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

The influence of age and sex on disease development in a novel animal model of cardiac cachexia.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS13539-011-0029-3

Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS13539-011-0029-3

Sickness behaviour, an animal equivalent to human quality of life, is improved in septic rats by G-CSF and antibiotic prophylaxis.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS13539-011-0029-3

Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

Effects of insulin-like growth factor I treatment on statural growth, body composition and phenotype of children with growth hormone insensitivity syndrome. GHIS Collaborative Group.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117996

Effects of interactions between IGFBPs and IGFs on the plasma clearance and in vivo biological activities of IGFs and IGF analogs

25 October 2018

1 reference

12 December 2020

Insulin-like growth factor I preserves host lean tissue mass in cancer cachexia

1 reference

12 December 2020

Insulin-like growth factor-1 activity is inhibited by interleukin-1 alpha, tumor necrosis factor-alpha, and interleukin-6

1 reference

12 December 2020

IGF-1 is downregulated in experimental cancer cachexia

1 reference

12 December 2020

10.1007/S13539-011-0029-3

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference